Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation

Regulatory Toxicology and Pharmacology

Volumn 69, Issue 3, 2014, Pages 524-528

  Basketter, David ^a   Kimber, Ian ^b  

^a DABMEB CONSULTANCY LTD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Hazard and risk categorisation; REACH; Respiratory sensitisers; Sensitisation potency; Skin sensitisers; Substances of very high concern; SVHC

Indexed keywords

CHROMIC ACID; CONTACT ALLERGEN; FORMALDEHYDE; INDUSTRIAL CHEMICAL; ISOEUGENOL; SKIN SENSITIZING CHEMICAL; UNCLASSIFIED DRUG; ALLERGEN;

ARTICLE; HAND ECZEMA; HEALTH CARE COST; HEALTH HAZARD; HUMAN; JOB CHANGE; NONHUMAN; OCCUPATIONAL ECZEMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; RISK MANAGEMENT; SKIN ALLERGY; SKIN SENSITIZATION; UNEMPLOYMENT; DERMATITIS, ALLERGIC CONTACT; IMMUNOLOGY; SKIN;

ALLERGENS; DERMATITIS, ALLERGIC CONTACT; HUMANS; QUALITY OF LIFE; RISK ASSESSMENT; SKIN;

EID: 84904042412     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.05.022     Document Type: Article

References (51)

1. REACH Commission of the European Communities. Regulation (EC). No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC,93/105/EC and 2000/21/EC. Off J Eur Union, L 396/1 of 30.12.2006.
2. ECHA Guidance on the application of the CLP criteria. Version 4.0 November 2013. Last accessed on the 28th November 2013. http://echa.europa.eu/documents/10162/13562/clp_en.pdf.
3. European Chemicals Agency, 2013. Last accessed 10/01/2014. http://echa.europa.eu/addressing-chemicals-of-concern/authorisation/substances-of-very-high-concern-identification.
4. Basketter D.A., Kimber I. Assessing the potency of respiratory allergens: challenges and uncertainties. Regul. Toxicol. Pharmacol. 2011, 61:365-372.
5. Kimber I., Basketter D.A. Categorisation of protein respiratory allergens: the case of Subtilisin. Regul. Toxicol. Pharmacol. 2014, 68:488-492.
6. Lachapelle J.M. A comparison of the irritant and allergenic properties of antiseptics. Eur. J. Dermatol. 2014, 24:3-9.
7. Ali Z., Dirks C.G., Ulrik C.S. Long-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthma. Chest 2013, 143:1649-1655.
8. Ma L., Danoff T.M., Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J. Allergy Clin. Immunol. 2013, 1642-1644. (S0091-6749).
9. Campi P., Pichler W.J. Quinolone hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002, 3:275-281.
10. Belton A.L., Chira T. Fatal anaphylactic reaction to hair dye. Am. J. Forensic Med. Pathol. 1997, 18:290-292.
11. Menné T., Maibach H.I. Hand Eczema 2000, CRC Press, Boca Raton. 2nd.
12. Clemmensen K.K., Carøe T.K., Thomsen S.F., Ebbehøj N.E., Agner T. Two-year follow-up survey of patients with allergic contact dermatitis from an occupational cohort. Is the prognosis dependent on the omnipresence of the allergen?. Br. J. Dermatol. 2013, 170:1100-1105.
13. Knoeller G.E., Mazurek J.M., Moorman J.E. Health-related quality of life among adults with work-related asthma in the United States. Qual. Life Res. 2013, 22:771-780.
14. Cvetkovski R.S., Zachariae R., Jensen H., Olsen J., Johansen J.D., Agner T. Prognosis of occupational hand eczema: a follow-up study. Arch. Dermatol. 2006, 142:305-311.
15. Kanerva L., Tarvainen K., Pinola A., Leino T., Granlund H., Estlander T., Jolanki R., Förström L. A single accidental exposure may result in a chemical burn, primary sensitization and allergic contact dermatitis. Contact Dermatitis 1994, 31:229-235.
16. Lindberg, M., Matura, M., 2011. Patch testing. In "Contact Dermatitis", 5th edition, chapter 13. Springer, Berlin, Eds Johansen, J.D., Frosch, P.F., Lepoittevin, J.-P., pp 439-464.
17. Jensen C.D., Andersen K.E. Course of contact allergy in consecutive eczema patients patch tested with TRUE test panels 1 and 2 at least twice over a 12-year period. Contact Dermatitis 2005, 52:242-246.
18. Valsecchi R., Rossi A., Bigardi A., Pigatto P.D. The loss of contact sensitization in man. Contact Dermatitis 1991, 24:183-186.
19. Kimber I., Gerberick G.F., Basketter D.A. Thresholds in contact sensitization: theoretical considerations and practical applications. Food Chem. Toxicol. 1999, 37:553-560.
20. Boukhman M.P., Maibach H.I. Thresholds in contact sensitization: immunologic mechanisms and experimental evidence in humans - an overview. Food Chem. Toxicol. 2001, 39:1125-1134.
21. Basketter D.A., Evans P.E., Gerberick G.F., Kimber I. Factors affecting thresholds in allergic contact dermatitis: safety and regulatory considerations. Contact Dermatitis 2002, 47:1-6.
22. Felter S.P., Robinson M.K., Basketter D.A., Gerberick G.F. A review of the scientific basis for default uncertainty factors for use in quantitative risk assessment of the induction of allergic contact dermatitis. Contact Dermatitis 2002, 47:257-266.
23. Felter S.P., Ryan C.A., Basketter D.A., Gerberick G.F. Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regul. Toxicol. Pharmacol. 2003, 37:1-10.
24. Api A.M., Basketter D.A., Cadby P.A., Cano M.F., Ellis G., Gerberick G.F., Griem P., McNamee P.M., Ryan C.A., Safford R. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul. Toxicol. Pharmacol. 2008, 52:3-23.
25. Safford R.J., Aptula A.O., Gilmour N. Refinement of the dermal sensitization threshold (DST) approach using a larger dataset and incorporating mechanistic chemistry domains. Regul. Toxicol. Pharmacol. 2011, 60:218-224.
26. Gerberick G.F., Robinson M.K., Felter S., White I., Basketter D.A. Understanding fragrance allergy using an exposure-based risk assessment approach. Contact Dermatitis 2001, 45:333-340.
27. Basketter D.A., Clapp C.J., Safford B.J., Jowsey I.R., McNamee P.M., Ryan C.A., Gerberick G.F. Preservatives and skin sensitisation quantitative risk assessment: risk benefit considerations. Dermatitis 2008, 19:20-27.
28. Basketter D.A. Methyldibromo glutaronitrile, skin sensitisation and quantitative risk assessment. Cutan. Ocul. Toxicol. 2010, 29:4-9.
29. Basketter D.A., Angelini G., Ingber A., Kern P., Menné T. Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium. Contact Dermatitis 2003, 49:1-7.
30. International Fragrance Association. Task IV: Validity of the QRA methodology & possibilities of further refinement. Last accessed 5th February 2014. http://www.ideaproject.info/taskiv.
31. Arnold S.M., Collins M.A., Graham C., Jolly A.T., Parod R.J., Poole A., Schupp T., Shiotsuka R.N., Woolhiser M.R. Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foam. Regul. Toxicol. Pharmacol. 2012, 64:504-515.
32. Basketter D.A., Broekhuizen C., Fieldsend M., Kirkwood S., Mascarenhas R., Maurer K., Pedersen C., Rodriguez C., Schiff H.-E. Defining occupational and consumer exposure limits for enzyme protein respiratory allergens under REACH. Toxicology 2010, 268:165-170.
33. Basketter D.A., Berg N., Broekhuizen C., Fieldsend M., Kirkwood S., Kliun C., Mathieu S., Rodriguez C. Enzymes in cleaning products: an overview of toxicological properties and risk assessment/management. Regul. Toxicol. Pharmacol. 2012, 64:117-123.
34. Basketter, D.A., Kruszewski, F., Mathieu, S., Kirchner, D.B., Panepinto, A., Fieldsend, M., Siegert, V., Barnes, F., Bookstaff, R., Simonsen M., Concoby B., 2014. Managing the risk of occupation allergy and asthma due to enzymes in the detergent industry. J. Occup. Environ. Hygiene, submitted.
35. García Gómez M., Urbanos Garrido R., Castañeda López R., López Menduiña P. Direct health care costs of occupational asthma in Spain: an estimation from 2008. Arch. Bronconeumol. 2012, 48:355-361.
36. Diepgen T.L., Scheidt R., Weisshaar E., John S.M., Hieke K. Cost of illness from occupational hand eczema in Germany. Contact Dermatitis 2013, 69:99-106.
37. Basketter D.A., Alepee N., Ashikaga T., Barroso J., Gilmour N., Goebel C., Hibatallah J., Hoffmann S., Kern P., Martinozzi-Teissier S., Maxwell G., Millet M., Reisinger K., Sakaguchi H., Schepky A., Tialhardat M., Templier M. Categorisation of chemicals according to their relative human skin sensitizing potency. Dermatitis 2014, 25:11-21.
38. Wahlberg J., Boman A. Guinea pig maximization test. Contact Allergy Predictive Test in Guinea Pigs 1985, 59-106. Karger, Basel. K.E. Andersen, H.I. Maibach (Eds.).
39. Gerberick G.F., Ryan C.A., Kern P.S., Schlatter H., Dearman R.J., Kimber I., Patlewicz G., Basketter D.A. Compilation of historical local lymph node assay data for the evaluation of skin sensitization alternatives. Dermatitis 2005, 16:157-202.
40. Allenby C.F., Goodwin B.F. Influence of detergent washing powders on minimal eliciting patch test concentrations of nickel and chromium. Contact Dermatitis 1983, 9:491-499.
41. Basketter D.A., Horev L., Slodovnik D., Merims S., Trattner A., Ingber A. Investigation of the threshold for allergic reactivity to chromium. Contact Dermatitis 2001, 44:264-266.
42. Hogan D.J., Dannaker C.J., Lal S., Maibach H.I. An international survey on the prognosis of occupational contact dermatitis of the hands. Derm. Beruf. Umwelt. 1990, 38:143-147.
43. Hald M., Agner T., Blands J., Ravn H., Johansen J.D. Allergens associated with severe symptoms of hand eczema and a poor prognosis. Contact Dermatitis 2009, 61:101-108.
44. Mälkönen T., Alanko K., Jolanki R., Luukkonen R., Aalto-Korte K., Lauerma A., Susitaival P. Long-term follow-up study of occupational hand eczema. Br. J. Dermatol. 2010, 163:999-1006.
45. Avnstorp C. Follow up of workers from the prefabricated concrete industry after the addition of ferrous sulphate to Danish cement. Contact Dermatitis 1989, 20:365-371.
46. Kadyk D.L., McCarter K., Achen F., Belsito D.V. Quality of life in patients with allergic contact dermatitis. J. Am. Acad. Dermatol. 2003, 49:1037-1048.
47. Geier J., Krautheim A., Uter W., Lessmann H., Schnuch A. Occupational contact allergy in the building trade in Germany: influence of preventive measures and changing exposure. Int. Arch. Occup. Environ. Health 2011, 84:403-411.
48. Fischer L.A., Voelund A., Andersen K.E., Menné T., Johansen J.D. The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes. Contact Dermatitis 2009, 61:201-208.
49. White J.M., White I.R., Glendinning A., Fleming J., Jefferies D., Basketter D.A., McFadden J.P., Buckley D.A. Frequency of allergic contact dermatitis to isoeugenol is increasing: a review of 3636 patients tested from 2001 to 2005. Br. J. Dermatol. 2007, 157:580-582.
50. Lysdal S.H., Johansen J.D. Fragrance contact allergic patients: strategies for use of cosmetic products and perceived impact on life situation. Contact Dermatitis 2009, 61:320-324.
51. Heisterberg M.V., Menné T., Johansen J.D. Fragrance allergy and quality of life - a case control study. Contact Dermatitis 2014, 70:81-89.